[ad_1] Activists protest the price of prescription drug costs in front of the U.S. Department of…
Tag: Johnson & Johnson
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
[ad_1] President Joe Biden speaks during an event at the National Institutes of Health in Bethesda,…
Here are JPMorgan’s top drug stock picks into earnings
[ad_1] JPMorgan is eyeing a few drug manufacturers ahead of their earnings reports as investors continue…
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
[ad_1] Activists protest the price of prescription drug costs in front of the U.S. Department of…
Jim Cramer says the best is yet to come at Oracle — plus, his thoughts on 4 more stocks
[ad_1] Jim Cramer’s daily rapid fire looks at stocks in the news outside the CNBC Investing…
Study links talc use to ovarian cancer — a potential boon for thousands suing J&J
[ad_1] In this photo illustration a bottle of Johnson & Johnson baby powder is displayed on…
Johnson & Johnson to pay $6.5 billion to resolve nearly all talc ovarian cancer lawsuits in U.S.
[ad_1] Johnson & Johnson on Wednesday said it plans to pay $6.5 billion over 25 years…
Judge withdraws from Medicare drug price case after stock ownership is revealed
[ad_1] Ohio Governor Mike DeWine, right, shakes hands with Judge Thomas Rose of the U.S. District…
These 10 medications are likely targets for Medicare price negotiations this fall
[ad_1] Merck & Co. Inc.’s Januvia brand medication, used to treat Type 2 diabetes. Daniel Acker…
Novavax shares jump after Covid vaccine maker posts surprise quarterly profit
[ad_1] Medical syringes and Novavax logo displayed in the background are seen in this illustration photo…
Here are the 5 price-target changes and 4 trades we made during this busy earnings week
[ad_1] In a jam-packed week of earnings, the Club executed multiple trades and elevated price targets…
Johnson & Johnson effort to resolve talc cancer lawsuits in bankruptcy fails a second time
[ad_1] In this photo illustration, a container of Johnson and Johnson baby powder is displayed on…
Johnson & Johnson to reduce its Kenvue stake by at least 80% through exchange offer
[ad_1] Kenvue, a unit of Johnson & Johnson’s consumer health business. CFOTO | Future Publishing |…
Kenvue CEO says consumers are spending on brand-name health products even as they pull back in other areas
[ad_1] Thibaut Mongon, CEO of Kenvue Inc. a Johnson & Johnson’s consumer-health business, speaks during an…